Oncology

Plasmacytoid dendritic cell-based cancer vaccines 1:43
Plasmacytoid dendritic cell-based cancer vaccines
Eric Halioua • 20 Apr 2022
Developing a therapeutic cancer vaccine for patients with NSCLC 2:41
Developing a therapeutic cancer vaccine for patients with NSCLC
Eric Halioua • 20 Apr 2022
Assessing PDC*mel, dendritic cell-based vaccine in melanoma 1:34
Assessing PDC*mel, dendritic cell-based vaccine in melanoma
Eric Halioua • 20 Apr 2022
Applications of stem cell gene therapy beyond genetic diseases 1:04
Applications of stem cell gene therapy beyond genetic diseases
Luigi Naldini • 7 Apr 2022
PiggyBac Transposon-generated CAR T-cells in solid tumors 1:13
PiggyBac Transposon-generated CAR T-cells in solid tumors
Shigeki Yagyu • 8 Apr 2022
CAR T-cell therapy for neuroblastoma 2:24
CAR T-cell therapy for neuroblastoma
Shigeki Yagyu • 8 Apr 2022
Optimizing the upscaling and outscaling of CAR T-cell therapies 4:06
Optimizing the upscaling and outscaling of CAR T-cell therapies
Saskia Rösch • 6 Apr 2022
Moving CAR T-cell therapies to earlier lines of therapy in multiple myeloma 2:30
Moving CAR T-cell therapies to earlier lines of therapy in multiple myeloma
Angela Krackhard • 6 Apr 2022
Enhancing the long-term functionality of CAR-T cells in solid tumors 1:23
Enhancing the long-term functionality of CAR-T cells in solid tumors
Shigeki Yagyu • 8 Apr 2022
The benefits of PiggyBac transposon-mediated CAR-T cell technology 2:37
The benefits of PiggyBac transposon-mediated CAR-T cell technology
Shigeki Yagyu • 8 Apr 2022
Developing individualized cancer therapies with neoantigen-specific TCRs 4:27
Developing individualized cancer therapies with neoantigen-specific TCRs
Angela Krackhard • 6 Apr 2022
Improving immune-imaging tools to assess cancer immunotherapies 5:33
Improving immune-imaging tools to assess cancer immunotherapies
Angela Krackhard • 6 Apr 2022
An overview of mouse models to study cell therapies for cancer 3:25
An overview of mouse models to study cell therapies for cancer
Juliane Mietz • 1 Apr 2022
Assessing immunotherapies with a novel tumor model using humanized mice 3:22
Assessing immunotherapies with a novel tumor model using humanized mice
Juliane Mietz • 1 Apr 2022
Improving the efficiency of cancer vaccines with adoptive T cell therapy approaches 1:33
Improving the efficiency of cancer vaccines with adoptive T cell therapy approaches
Chiara Bonini • 1 Apr 2022
Adoptive T cell therapies for solid tumors: what are the key challenges? 1:38
Adoptive T cell therapies for solid tumors: what are the key challenges?
Chris Klebanoff • 1 Apr 2022
The content of VJRegenMed is intended for healthcare professionals